Related Experiment Video
Updated: Aug 19, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
Cephalostatin 1 inactivates Bcl-2 by hyperphosphorylation independent of M-phase arrest and DNA damage
Irina M Müller1, Verena M Dirsch, Anita Rudy
1Department of Pharmacy, Center of Drug Research, University of Munich, Germany.
Abstract:
Cephalostatin 1 is a marine product that induces a novel cytochrome c-independent apoptotic pathway in Jurkat leukemia T cells (Cancer Res 63:8869-8876, 2003). Here, we show that overexpression of the antiapoptotic protein Bcl-2 protects cells only partially against cephalostatin 1-induced apoptosis. The mechanism of Bcl-2 inactivation by cephalostatin 1 is based on hyperphosphorylation of Bcl-2 on Thr69 and Ser87 because Jurkat cells overexpressing a Bcl-2 protein with mutations on both phosphorylation sites were completely protected against cephalostatin 1. In search of the kinase responsible for Bcl-2 phosphorylation, c-Jun NH2-terminal kinase (JNK) was found to be activated by cephalostatin 1. Reduction of Bcl-2 phosphorylation by the specific JNK inhibitor (anthra(1,3-cd)pyrazol-6(2H)-one) SP600125 suggested a crucial role for JNK in this process. JNK activation was not a consequence of DNA damage, a known stimulus of JNK, because cephalostatin 1 did not induce DNA lesions as shown by the comet assay. Arrest in M-phase is also demonstrated to be associated with JNK activation. However, cephalostatin 1 does not evoke an arrest in M-phase as shown by flow cytometry. Together, cephalostatin 1 is shown to induce JNK activation with subsequent Bcl-2 phosphorylation and inactivation. Reported triggers, such as the induction of an M-phase arrest or DNA damage are not involved in this process, suggesting a novel mechanism for cephalostatin 1-mediated Bcl-2 hyperphosphorylation.
Insights
Marine product cephalostatin 1 triggers apoptosis in leukemia cells by activating c-Jun NH2-terminal kinase (JNK), leading to Bcl-2 protein inactivation. This occurs independently of DNA damage or M-phase arrest, revealing a novel cell death mechanism.
Area of Science:
- Molecular Biology
- Cell Biology
- Pharmacology
Background:
- Cephalostatin 1, a marine compound, induces apoptosis in Jurkat leukemia T cells via a unique pathway.
- The antiapoptotic protein Bcl-2 plays a role in cellular resistance to apoptosis.
Purpose of the Study:
- To elucidate the mechanism by which cephalostatin 1 induces apoptosis, focusing on the role of Bcl-2.
- To identify the specific signaling pathway and kinase involved in cephalostatin 1-induced Bcl-2 inactivation.
Main Methods:
- Overexpression of Bcl-2 and mutated Bcl-2 in Jurkat cells.
- Treatment with cephalostatin 1 and a c-Jun NH2-terminal kinase (JNK) inhibitor (SP600125).
- Analysis of Bcl-2 phosphorylation, JNK activation, DNA damage (comet assay), and cell cycle progression (flow cytometry).
Main Results:
- Overexpression of Bcl-2 only partially protected cells against cephalostatin 1-induced apoptosis.
- Cephalostatin 1 induced hyperphosphorylation of Bcl-2 at Thr69 and Ser87, inactivating its function.
- Mutations preventing phosphorylation at Thr69 and Ser87 conferred complete protection.
- Cephalostatin 1 activated JNK, and JNK inhibition reduced Bcl-2 phosphorylation.
- Cephalostatin 1 did not induce DNA damage or M-phase arrest.
Conclusions:
- Cephalostatin 1 induces JNK activation, leading to Bcl-2 hyperphosphorylation and inactivation, thereby promoting apoptosis.
- This mechanism is independent of DNA damage and M-phase arrest, suggesting a novel pathway for apoptosis induction by marine natural products.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...

